Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Chemical Biology & Drug Design|November 26, 2022
Design and biological characterization of a series of dual mechanism ERK1/2 inhibitors with a Triazolopyridinone coreSajedeh Lotfaliansaremi, Stephen Cornwell, Candice Casillas, et al.FEBS Letters|November 25, 2010
Structural basis of CX-4945 binding to human protein kinase CK2Andrew D Ferguson, Payal R Sheth, Andrea D Basso, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinityGregory A Reichard, Cheryl A Grice, Neng-Yang Shih, et al.Organic Letters|November 7, 2003
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonistsGregory A Reichard, Carmine Stengone, Sunil Paliwal, et al.Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Cyclobutane derivatives as potent NK1 selective antagonistsMichelle Laci Wrobleski, Gregory A Reichard, Sunil Paliwal, et al.Journal of Medicinal Chemistry|August 23, 2021
Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of CancerPeter Q Huang, Brant C Boren, Sayee G Hegde, et al.Bioorganic & Medicinal Chemistry Letters|September 18, 2010
Discovery of a series of potent, orally active α,α-disubstituted piperidine NK(1) antagonistsDong Xiao, Cheng Wang, Anandan Palani, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonistsSunil Paliwal, Gregory A Reichard, Sapna Shah, et al.ACS Medicinal Chemistry Letters|June 24, 2015
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of InflammationWilliam T McElroy, Zheng Tan, Ginny Ho, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2005
Cyclic urea derivatives as potent NK1 selective antagonistsHo-Jane Shue, Xiao Chen, Neng-Yang Shih, et al.Pageof 2